|
Name: JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)
Type: Synthetic cannabinoid
AKA: JWH-122
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
JWH-122, a synthetic cannabinoid, was developed by John W. Huffman in the 2000s. It is part of a series of synthetic cannabinoids used for research into the endocannabinoid system. Its recreational use has led to its regulation due to its psychoactive effects and potential for abuse.
|
|
V. Legal Information
JWH-122, a synthetic cannabinoid, is often regulated under analog laws due to its psychoactive effects. In the US, it might be controlled under the Federal Analog Act if deemed similar to other controlled substances.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
JWH-122 is a synthetic cannabinoid known for its psychoactive effects. It acts as an upper, producing effects similar to THC. Short-term use can lead to altered perception and mood, but long-term health impacts are poorly documented. Overdose risks include severe psychological effects and potential toxicity. Safe use requires caution due to limited research on its long-term effects. Recent studies investigate its potency and health risks compared to other cannabinoids.  |
|
VII. Psychological Effects
JWH-122, a synthetic cannabinoid, affects cannabinoid receptors, causing altered mood and perception. Immediate effects include euphoria and relaxation, with long-term use potentially leading to cognitive impairments and psychological issues. Research focuses on its safety and psychological impact.
 |
|
VIII. Culture
JWH-122 is a synthetic cannabinoid, classifying it as a downer. Short-term use induces relaxation and altered perceptions, while long-term use can lead to dependence and cognitive impairment. Overdose risks include severe sedation, cognitive effects, and potential psychosis. Safe dosages are not well-established, with minimal use recommended. Recent research highlights its high potency and associated risks of cognitive effects. Physical effects include drowsiness, altered perceptions, and potential for impaired motor skills.
 |